Trial Outcomes & Findings for Efficacy and Neural Mediators of Response to Trauma Management Therapy for PTSD (NCT NCT03449576)

NCT ID: NCT03449576

Last Updated: 2024-07-24

Results Overview

The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5; Weathers et al. 2013; 2017) is a 20 item semi-structured instrument for the diagnosis and assessment of severity of posttraumatic stress disorder (PTSD). Each DSM-5 item is rated on a 0 (absent) to 4 (extreme/incapacitating) scale, and total score is calculated by summing severity scores across items. Total CAPS-5 severity can range from 0 to 80. \[edited 2/24/24: Higher scores mean a worse outcome.\]

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

69 participants

Primary outcome timeframe

CAPS-5 will be assessed at two time-points per participant: before starting treatment i.e. pre-treatment (week 0) and at completion of treatment, i.e. post-treatment (week 8).

Results posted on

2024-07-24

Participant Flow

Participant milestones

Participant milestones
Measure
Trauma Management Therapy
Trauma Management Therapy (TMT) consists of a combination of 12 sessions of individualized exposure therapy and 24 sessions of group-based social and emotion rehabilitation. Trauma Management Therapy: Trauma Management Therapy (TMT) consists of a combination of 12 sessions of individualized exposure therapy and 24 sessions of group-based social and emotion rehabilitation.
Exposure Therapy With Psychoeducation
Exposure Therapy with Psychoeducation (EXP+EDU) consists of a combination of 12 sessions of individualized exposure therapy and 24 session of group-based psychoeducation. Exposure Therapy with Psychotherapy group: Exposure Therapy with Psychoeducation (EXP+EDU) consists of a combination of 12 sessions of individualized exposure therapy and 24 session of group-based psychoeducation.
Overall Study
STARTED
40
29
Overall Study
COMPLETED
29
24
Overall Study
NOT COMPLETED
11
5

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Efficacy and Neural Mediators of Response to Trauma Management Therapy for PTSD

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Trauma Management Therapy
n=40 Participants
Trauma Management Therapy (TMT) consists of a combination of 12 sessions of individualized exposure therapy and 24 sessions of group-based social and emotion rehabilitation. Trauma Management Therapy: Trauma Management Therapy (TMT) consists of a combination of 12 sessions of individualized exposure therapy and 24 sessions of group-based social and emotion rehabilitation.
Exposure Therapy With Psychoeducation
n=29 Participants
Exposure Therapy with Psychoeducation (EXP+EDU) consists of a combination of 12 sessions of individualized exposure therapy and 24 session of group-based psychoeducation. Exposure Therapy with Psychotherapy group: Exposure Therapy with Psychoeducation (EXP+EDU) consists of a combination of 12 sessions of individualized exposure therapy and 24 session of group-based psychoeducation.
Total
n=69 Participants
Total of all reporting groups
Age, Continuous
51.65 years
STANDARD_DEVIATION 9.40 • n=5 Participants
43.83 years
STANDARD_DEVIATION 10.35 • n=7 Participants
48.36 years
STANDARD_DEVIATION 10.49 • n=5 Participants
Sex: Female, Male
Female
12 Participants
n=5 Participants
8 Participants
n=7 Participants
20 Participants
n=5 Participants
Sex: Female, Male
Male
28 Participants
n=5 Participants
21 Participants
n=7 Participants
49 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
n=5 Participants
3 Participants
n=7 Participants
5 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
38 Participants
n=5 Participants
26 Participants
n=7 Participants
64 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
17 Participants
n=5 Participants
8 Participants
n=7 Participants
25 Participants
n=5 Participants
Race (NIH/OMB)
White
19 Participants
n=5 Participants
19 Participants
n=7 Participants
38 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
2 Participants
n=5 Participants
1 Participants
n=7 Participants
3 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants

PRIMARY outcome

Timeframe: CAPS-5 will be assessed at two time-points per participant: before starting treatment i.e. pre-treatment (week 0) and at completion of treatment, i.e. post-treatment (week 8).

Population: Data analysis at pre-treatment was limited to participants who had completed this measure. At post-treatment, analysis was limited to participants who had begun treatment and had completed this measure.

The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5; Weathers et al. 2013; 2017) is a 20 item semi-structured instrument for the diagnosis and assessment of severity of posttraumatic stress disorder (PTSD). Each DSM-5 item is rated on a 0 (absent) to 4 (extreme/incapacitating) scale, and total score is calculated by summing severity scores across items. Total CAPS-5 severity can range from 0 to 80. \[edited 2/24/24: Higher scores mean a worse outcome.\]

Outcome measures

Outcome measures
Measure
Trauma Management Therapy
n=29 Participants
Trauma Management Therapy (TMT) consists of a combination of 12 sessions of individualized exposure therapy and 24 sessions of group-based social and emotion rehabilitation. Trauma Management Therapy: Trauma Management Therapy (TMT) consists of a combination of 12 sessions of individualized exposure therapy and 24 sessions of group-based social and emotion rehabilitation.
Exposure Therapy With Psychoeducation
n=24 Participants
Exposure Therapy with Psychoeducation (EXP+EDU) consists of a combination of 12 sessions of individualized exposure therapy and 24 session of group-based psychoeducation. Exposure Therapy with Psychotherapy group: Exposure Therapy with Psychoeducation (EXP+EDU) consists of a combination of 12 sessions of individualized exposure therapy and 24 session of group-based psychoeducation.
Change in Clinician-Administered PTSD Scale for DSM-5
Pre-treatment
38.39 score on a scale
Standard Error 2.834358
35.67 score on a scale
Standard Error 1.76075
Change in Clinician-Administered PTSD Scale for DSM-5
Post-treatment
27.15 score on a scale
Standard Error 4.324715
29.31 score on a scale
Standard Error 2.813394

PRIMARY outcome

Timeframe: SAS will be assessed at two time-points: before starting treatment i.e. pre-treatment (week 0) and at completion of treatment, i.e. post-treatment (week 8).

Population: Data analysis at pre-treatment was limited to participants who had completed this measure. At post-treatment, analysis was limited to participants who had begun treatment and had completed this measure.

The Social Adjustment Scale (SAS; Weissman \& Bothwell, 1976) is a 54 item self-report measure that assesses social adjustment in six social areas of functioning including work, social and leisure activities, extended family, marital, parental, and family. Each item is rated on a five point scale, and within each of domain items are averaged. Thus, scores in each domain can range between 1 (high social adjustment) and 5 (low social adjustment). \[edited 2/24/24 Higher scores mean a worse outcome.\]

Outcome measures

Outcome measures
Measure
Trauma Management Therapy
n=29 Participants
Trauma Management Therapy (TMT) consists of a combination of 12 sessions of individualized exposure therapy and 24 sessions of group-based social and emotion rehabilitation. Trauma Management Therapy: Trauma Management Therapy (TMT) consists of a combination of 12 sessions of individualized exposure therapy and 24 sessions of group-based social and emotion rehabilitation.
Exposure Therapy With Psychoeducation
n=24 Participants
Exposure Therapy with Psychoeducation (EXP+EDU) consists of a combination of 12 sessions of individualized exposure therapy and 24 session of group-based psychoeducation. Exposure Therapy with Psychotherapy group: Exposure Therapy with Psychoeducation (EXP+EDU) consists of a combination of 12 sessions of individualized exposure therapy and 24 session of group-based psychoeducation.
Change in Social Adjustment Scale - Self-Report
Pre-treatment
2.855 mean score on a scale
Standard Error 0.1321421
3.168 mean score on a scale
Standard Error 0.1061295
Change in Social Adjustment Scale - Self-Report
Post-treatment
2.953 mean score on a scale
Standard Error 0.1869682
3.289 mean score on a scale
Standard Error 0.125691

PRIMARY outcome

Timeframe: The PCL-5 will be assessed at two time-points: before starting treatment i.e. pre-treatment (week 0) and at completion of treatment, i.e. post-treatment (week 8).

Population: Data analysis at pre-treatment was limited to participants who had completed this measure. At post-treatment, analysis was limited to participants who had begun treatment and had completed this measure.

The PTSD Checklist for DSM-5 (PCL-5; Weathers et al., 2013; Bovin et al., 2016) is a 20 item self-report measure assessing DSM-5 PTSD symptom severity. Each DSM-5 item is rated on a 0 (absent) to 4 (extreme/incapacitating) scale, and total score is calculated by summing severity scores across items. Total CAPS-5 severity can range from 0 to 80. Higher scores mean a worse outcome.

Outcome measures

Outcome measures
Measure
Trauma Management Therapy
n=29 Participants
Trauma Management Therapy (TMT) consists of a combination of 12 sessions of individualized exposure therapy and 24 sessions of group-based social and emotion rehabilitation. Trauma Management Therapy: Trauma Management Therapy (TMT) consists of a combination of 12 sessions of individualized exposure therapy and 24 sessions of group-based social and emotion rehabilitation.
Exposure Therapy With Psychoeducation
n=24 Participants
Exposure Therapy with Psychoeducation (EXP+EDU) consists of a combination of 12 sessions of individualized exposure therapy and 24 session of group-based psychoeducation. Exposure Therapy with Psychotherapy group: Exposure Therapy with Psychoeducation (EXP+EDU) consists of a combination of 12 sessions of individualized exposure therapy and 24 session of group-based psychoeducation.
Change in PTSD Checklist for DSM-5
Pre-treatment
53.66 score on a scale
Standard Error 2.594175
56.92 score on a scale
Standard Error 2.917909
Change in PTSD Checklist for DSM-5
Post-treatment
40.04 score on a scale
Standard Error 3.610813
46.53 score on a scale
Standard Error 4.15784

SECONDARY outcome

Timeframe: AQ will be assessed at two time-points: before starting treatment i.e. pre-treatment (week 0) and at completion of treatment, i.e. post-treatment (week 8).

Population: Data analysis at pre-treatment was limited to participants who had completed this measure. At post-treatment, analysis was limited to participants who had begun treatment and had completed this measure.

Change in Aggression Questionnaire (AQ; Buss \& Warren, 2000) is a 34 item self-report measure that assesses severity of self-perceived aggression and anger. Each item is rated on a 1 (Not at all like me) to 5 (Completely like me) scale, and scores of all items are summed. Scores can range from 34 to 170. Higher scores mean a worse outcome.

Outcome measures

Outcome measures
Measure
Trauma Management Therapy
n=29 Participants
Trauma Management Therapy (TMT) consists of a combination of 12 sessions of individualized exposure therapy and 24 sessions of group-based social and emotion rehabilitation. Trauma Management Therapy: Trauma Management Therapy (TMT) consists of a combination of 12 sessions of individualized exposure therapy and 24 sessions of group-based social and emotion rehabilitation.
Exposure Therapy With Psychoeducation
n=24 Participants
Exposure Therapy with Psychoeducation (EXP+EDU) consists of a combination of 12 sessions of individualized exposure therapy and 24 session of group-based psychoeducation. Exposure Therapy with Psychotherapy group: Exposure Therapy with Psychoeducation (EXP+EDU) consists of a combination of 12 sessions of individualized exposure therapy and 24 session of group-based psychoeducation.
Change in Aggression Questionnaire
Pre-treatment
59 score on a scale
Standard Error 1.83896
64.62 score on a scale
Standard Error 1.715036
Change in Aggression Questionnaire
Post-treatment
58.92 score on a scale
Standard Error 2.066746
62.18 score on a scale
Standard Error 3.193785

SECONDARY outcome

Timeframe: ITS will be assessed at two time-points: before starting treatment i.e. pre-treatment (week 0) and at completion of treatment, i.e. post-treatment (week 8).

Population: Data analysis at pre-treatment was limited to participants who had completed this measure. At post-treatment, analysis was limited to participants who had begun treatment and had completed this measure.

Change in Interpersonal Trust Scale (ITS; Rotter, 1967) is a 25 item self-report measure that assesses trust within relationships. Each item is rated on a 1 (low trust) to 5 (high trust) scale, and total scores can range from 25 to 125. \[edited 2/24/24: Higher scores mean a better outcome.\]

Outcome measures

Outcome measures
Measure
Trauma Management Therapy
n=29 Participants
Trauma Management Therapy (TMT) consists of a combination of 12 sessions of individualized exposure therapy and 24 sessions of group-based social and emotion rehabilitation. Trauma Management Therapy: Trauma Management Therapy (TMT) consists of a combination of 12 sessions of individualized exposure therapy and 24 sessions of group-based social and emotion rehabilitation.
Exposure Therapy With Psychoeducation
n=24 Participants
Exposure Therapy with Psychoeducation (EXP+EDU) consists of a combination of 12 sessions of individualized exposure therapy and 24 session of group-based psychoeducation. Exposure Therapy with Psychotherapy group: Exposure Therapy with Psychoeducation (EXP+EDU) consists of a combination of 12 sessions of individualized exposure therapy and 24 session of group-based psychoeducation.
Change in Interpersonal Trust Scale
Pre-treatment
60.21 score on a scale
Standard Error 2.266907
57.54 score on a scale
Standard Error 1.917671
Change in Interpersonal Trust Scale
Post-treatment
63.33 score on a scale
Standard Error 2.491774
60.41 score on a scale
Standard Error 4.027533

Adverse Events

Trauma Management Therapy

Serious events: 1 serious events
Other events: 0 other events
Deaths: 2 deaths

Exposure Therapy With Psychoeducation

Serious events: 1 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Trauma Management Therapy
n=40 participants at risk
Trauma Management Therapy (TMT) consists of a combination of 12 sessions of individualized exposure therapy and 24 sessions of group-based social and emotion rehabilitation. Trauma Management Therapy: Trauma Management Therapy (TMT) consists of a combination of 12 sessions of individualized exposure therapy and 24 sessions of group-based social and emotion rehabilitation.
Exposure Therapy With Psychoeducation
n=29 participants at risk
Exposure Therapy with Psychoeducation (EXP+EDU) consists of a combination of 12 sessions of individualized exposure therapy and 24 session of group-based psychoeducation. Exposure Therapy with Psychotherapy group: Exposure Therapy with Psychoeducation (EXP+EDU) consists of a combination of 12 sessions of individualized exposure therapy and 24 session of group-based psychoeducation.
Cardiac disorders
Syncopal episode
0.00%
0/40 • 7 months, 3 weeks
Participants were assessed across a period of seven months and three weeks, including seven weeks of treatment and a six month follow-up period.
3.4%
1/29 • 7 months, 3 weeks
Participants were assessed across a period of seven months and three weeks, including seven weeks of treatment and a six month follow-up period.
Psychiatric disorders
Psychiatric hospitalization
2.5%
1/40 • 7 months, 3 weeks
Participants were assessed across a period of seven months and three weeks, including seven weeks of treatment and a six month follow-up period.
0.00%
0/29 • 7 months, 3 weeks
Participants were assessed across a period of seven months and three weeks, including seven weeks of treatment and a six month follow-up period.

Other adverse events

Adverse event data not reported

Additional Information

Dr. Shirley Groer (Scientific Program Manager)

Rehabilitation Research & Development

Phone: 202-553-9899

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place